QGel Secures latest round of financing with $12 million in funding
12 Dec 2016

The New York Times published a big feature on private equity over the weekend. It takes a slightly lighter touch than certain past magazine covers… A few takeaways:

QGel, a Lausanne, Switzerland-based biomaterials company developing synthetic gels for 3D in vitro growth of miniature human organs and tumors, raised $12 million in funding.

Continue reading…

Back to News and Media